About Protalix Biotherapeutics Inc
- Industry: Biotechnology
- Exchange: NYSE MKT LLC
- Country: US
- Website: https://protalix.com/
Frequently Asked Questions
What is the 52-week range for PLX?
The 52-week high is $3.19 and the 52-week low is $1.6.
What is the P/E ratio for PLX?
The Price to Earnings (P/E) ratio is 11.50.
What is the dividend yield for PLX?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is 31.61%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is 23.50%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 3.00.
Analyst Recommendation Trends
Wall Street analyst consensus for PLX over the last few months:
Latest PLX News
Netflix downgraded, SanDisk initiated: Wall Street's top analyst calls
Netflix downgraded, SanDisk initiated: Wall Street's top analyst calls
Protalix BioTherapeutics, Inc. (PLX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Protalix BioTherapeutics, Inc. (PLX) Morgan Stanley 24th Annual Global Healthcare Conference September 16, 2026 1:05 PM EDTCompany ParticipantsGilad Mamlok...
HC Wainwright & Co. Reiterates Buy on Protalix BioTherapeutics, Maintains $12 Price Target
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Protalix BioTherapeutics (AMEX:PLX) with a Buy and maintains $12 price target.
Protalix BioTherapeutics to Participate in Upcoming September 2026 Investor Conferences
Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the discovery, development, production, and commercialization of innovative therapeutics for rare diseases with significant unmet needs, today announced that Gilad Mamlok, Senior Vice President and Chief Financial Officer, is scheduled to participate in the following two upcoming investor conferences in New York City, New York:
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-09-03 | Schwartz Aharon | +8,500 | - | - |
| 2026-09-03 | Schwartz Aharon | +17,000 | - | - |
| 2026-09-03 | Elze Christian | +8,500 | - | - |
| 2026-09-03 | Elze Christian | +17,000 | - | - |
| 2026-09-03 | Ben Zvi Shmuel | +8,500 | - | - |
| 2026-09-03 | Ben Zvi Shmuel | +17,000 | - | - |
| 2026-09-03 | Forster Eliot | +8,500 | - | - |
| 2026-09-03 | Forster Eliot | +17,000 | - | - |
| 2026-09-03 | Bashan Dror | +160,000 | - | - |
| 2026-09-03 | Bashan Dror | +320,000 | - | - |
| 2026-09-03 | Naos Yaron | +56,000 | - | - |
| 2026-09-03 | Naos Yaron | +112,000 | - | - |
| 2026-09-03 | Melincoff Gwen A | +8,500 | - | - |
| 2026-09-03 | Melincoff Gwen A | +17,000 | - | - |
| 2026-09-03 | Boudes Pol F | +8,500 | - | - |
| 2026-09-03 | Boudes Pol F | +17,000 | - | - |
| 2026-09-03 | Bar-Shalev Amos | +8,500 | - | - |
| 2026-09-03 | Bar-Shalev Amos | +17,000 | - | - |
| 2025-12-19 | Bashan Dror | +56,000 | $1.81 | $101,360 |
| 2025-11-18 | Bar-Shalev Amos | -168 | $1.87 | $314 |